https://retacompare.com/news/ai-uncovers-surprises-in-unapproved-weight-loss-drug-use 2026-10-22T02:38:47.000Z RetatrutideCompare en 2026-10-22T02:38:47.000Z AI Uncovers Surprises in Unapproved Weight-Loss Drug Use Weight Loss, Retatrutide https://retacompare.com/news/latest-developments-in-retatrutide-for-weight-loss-by-2026 2026-10-22T02:30:37.000Z RetatrutideCompare en 2026-10-22T02:30:37.000Z Latest Developments in Retatrutide for Weight Loss by 2026 Market News, Retatrutide https://retacompare.com/news/new-glp-1-agonist-in-trials-retatrutide-s-potential-impact 2026-10-21T21:01:00.000Z RetatrutideCompare en 2026-10-21T21:01:00.000Z New GLP-1 Agonist in Trials: Retatrutide's Potential Impact Clinical Trials, Retatrutide https://retacompare.com/news/harvard-gazette-explores-glp-1-agonist-use-in-obesity-treatment 2026-10-21T17:15:08.000Z RetatrutideCompare en 2026-10-21T17:15:08.000Z Harvard Gazette Explores GLP-1 Agonist Use in Obesity Treatment Weight Loss, Retatrutide https://retacompare.com/news/glp-1-agonists-and-retatrutide-emerging-trends-in-obesity-treatment 2026-10-21T17:06:36.000Z RetatrutideCompare en 2026-10-21T17:06:36.000Z GLP-1 Agonists and Retatrutide: Emerging Trends in Obesity Treatment Market News, Retatrutide https://retacompare.com/news/incretin-drug-shows-potential-in-treating-sleep-apnea 2026-10-21T15:59:06.000Z RetatrutideCompare en 2026-10-21T15:59:06.000Z Incretin Drug Shows Potential in Treating Sleep Apnea Clinical Trials, Retatrutide https://retacompare.com/news/lab-tests-reveal-concerns-with-experimental-weight-loss-drug 2026-10-21T13:01:00.000Z RetatrutideCompare en 2026-10-21T13:01:00.000Z Lab Tests Reveal Concerns with Experimental Weight Loss Drug Weight Loss, Retatrutide https://retacompare.com/news/pennsylvania-medicaid-ends-coverage-for-obesity-medications 2026-10-21T12:49:00.000Z RetatrutideCompare en 2026-10-21T12:49:00.000Z Pennsylvania Medicaid Ends Coverage for Obesity Medications Market News, Retatrutide https://retacompare.com/news/gender-disparities-in-glp-1-usage-men-less-represented 2026-10-21T08:37:27.000Z RetatrutideCompare en 2026-10-21T08:37:27.000Z Gender Disparities in GLP-1 Usage: Men Less Represented Market News, Retatrutide https://retacompare.com/news/cosmetic-industry-adapts-to-changes-from-obesity-drug-use 2026-10-21T06:02:00.000Z RetatrutideCompare en 2026-10-21T06:02:00.000Z Cosmetic Industry Adapts to Changes from Obesity Drug Use Market News, Retatrutide https://retacompare.com/news/glp-1-drugs-and-cancer-risk-implications-for-retatrutide-safety 2026-10-21T04:11:28.000Z RetatrutideCompare en 2026-10-21T04:11:28.000Z GLP-1 Drugs and Cancer Risk: Implications for Retatrutide Safety Clinical Trials, Retatrutide https://retacompare.com/news/retatrutide-side-effects-discussed-on-reddit-amid-glp-1-research 2026-10-20T17:52:14.000Z RetatrutideCompare en 2026-10-20T17:52:14.000Z Retatrutide Side Effects Discussed on Reddit Amid GLP-1 Research Patient Experiences, Retatrutide